Dr. Stefan O Ciurea, MD
Claim this profileUniversity of California, Irvine (UCI) Health - UC Irvine Medical Center
Studies Multiple Myeloma
Studies Plasma Cell Neoplasm
6 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Stefan O Ciurea, MD is currently running
CTO1681
for Preventing Side Effects in Cancer Therapy
This is an interventional study to evaluate the use of CTO1681 in preventing or reducing CAR T-cell-induced toxicities like cytokine release syndrome (CRS). This study will enroll adult patients with DLBCL who are scheduled to receive CD19-directed CAR T-cell therapy. The first phase of the study will be open label with dose escalation. Participants will start taking CTO1681 just prior to receiving their CAR T-cell therapy and continue to take the study drug three times daily for a total of 15 days.
Recruiting1 award Phase 1 & 2
Iberdomide vs Lenalidomide
for Multiple Myeloma
This trial is testing two treatments, iberdomide and lenalidomide, to see which one is better at preventing cancer from coming back in patients with newly diagnosed multiple myeloma after a stem cell transplant. These treatments help the immune system fight off cancer cells. Lenalidomide has been used for the treatment of multiple myeloma, showing effectiveness and improving survival outcomes.
Recruiting2 awards Phase 3
More about Stefan O Ciurea, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Stefan O Ciurea, MD has experience with
- Fludarabine
- Lenalidomide
- Cyclophosphamide
- Idecabtagene Vicleucel
- Melphalan
- Total Body Irradiation
Breakdown of trials Stefan O Ciurea, MD has run
Multiple Myeloma
Plasma Cell Neoplasm
Uterine Tumors
Hematological Malignancies
Bone Marrow Transplant
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stefan O Ciurea, MD specialize in?
Stefan O Ciurea, MD focuses on Multiple Myeloma and Plasma Cell Neoplasm. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Stefan O Ciurea, MD currently recruiting for clinical trials?
Yes, Stefan O Ciurea, MD is currently recruiting for 4 clinical trials in Orange California. If you're interested in participating, you should apply.
Are there any treatments that Stefan O Ciurea, MD has studied deeply?
Yes, Stefan O Ciurea, MD has studied treatments such as Fludarabine, Lenalidomide, Cyclophosphamide.
What is the best way to schedule an appointment with Stefan O Ciurea, MD?
Apply for one of the trials that Stefan O Ciurea, MD is conducting.
What is the office address of Stefan O Ciurea, MD?
The office of Stefan O Ciurea, MD is located at: University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange, California 92868 United States. This is the address for their practice at the University of California, Irvine (UCI) Health - UC Irvine Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.